Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15477579 | 0.95 | TSHR (0.62) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL23322250 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL23322097 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL23322030 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL23321986 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL23321803 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL23321537 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL23321794 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL23322183 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL23321525 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240409563-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. | 2024-12-12 | — | — | US | claimed |
| EP-4448536-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. (US) | 2024-10-23 | — | — | EP | claimed |
| CN-118401532-A | High-purity polysiloxane macromer and preparation method thereof | 盖列斯特有限公司 | 2024-07-26 | — | — | CN | claimed |
| WO-2023113779-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. (US) | 2023-06-22 | — | — | WO | claimed |
| US-20230183273-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. | 2023-06-15 | — | — | US | claimed |
| US-11597789-B2 | Materials for hydrophilic interaction chromatography and processes for preparation and use thereof for analysis of glycoproteins and glycopeptides | WATERS TECHNOLOGIES CORPORATION (US) | 2023-03-07 | — | — | US | claimed |
| CN-110817889-B | Preparation method of toughened silica aerogel, toughened silica aerogel and application of toughened silica aerogel | 上海中南建筑材料有限公司 | 2021-07-20 | — | — | CN | claimed |
| US-10835644-B2 | Surface-modified metal and method for modifying metal surface | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2020-11-17 | — | — | US | claimed |
| CN-110817889-A | Preparation method of toughened silica aerogel, toughened silica aerogel and application of toughened silica aerogel | 福建六树网络科技有限公司 | 2020-02-21 | — | — | CN | claimed |
| US-10251980-B2 | Surface-modified metal and method for modifying metal surface | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2019-04-09 | — | — | US | claimed |
| WO-2003093785-A2 | BIOCHIPS WITH SURFACES COATED WITH POLYSACCHARIDE BASED HYDROGELS | CIPHERGEN BIOSYSTEMS, INC. (US) | 2003-11-13 | — | — | WO | claimed |
| WO-2003079402-A2 | LATEX BASED ADSORBENT CHIP | CIPHERGEN BIOSYSTEMS, INC. (US) | 2003-09-25 | — | — | WO | claimed |
| US-20030124371-A1 | Hydrophobic surface chip | CIPHERGEN BIOSYSTEMS, INC. | 2003-07-03 | — | — | US | claimed |
| WO-2003040700-A1 | HYDROPHOBIC SURFACE CHIP | CIPHERGEN BIOSYSTEMS, INC. (US) | 2003-05-15 | — | — | WO | claimed |
| EP-0791635-B1 | Preapplied silicone threadlocker and sealant | LOCTITE CORP (US) | 2003-05-02 | — | — | EP | claimed |
| US-20030032043-A1 | Latex based adsorbent chip | CIPHERGEN BIOSYSTEMS, INC. | 2003-02-13 | — | — | US | claimed |
| US-20030017464-A1 | Latex based adsorbent chip | CIPHERGEN BIOSYSTEMS, INC. | 2003-01-23 | — | — | US | claimed |
| EP-0593297-B1 | Resin composition for coating and paint | HITACHI CHEMICAL CO LTD (JP) | 1997-04-16 | — | — | EP | claimed |
| US-5539051-A | ACRYLATE RESIN AND ADDITION TYPE RESIN WITH PENDANT SILICON CONTAINING GROUPS, FOR CONCRETE, MASONRY, NONSTAINING | HITACHI CHEMICAL COMPANY CO., LTD. (JP) | 1996-07-23 | — | — | US | claimed |
| EP-0593297-A1 | Resin composition for coating and paint | HITACHI CHEMICAL CO., LTD. (JP) | 1994-04-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409563-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | SSRP1, RPLP2, RPLP1 | TSHR 1897/4885ALDH1A1 837/4885CYP3A4 1562/4885 |
| US-20230183273-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | SSRP1, RPLP2, RPLP1 | TSHR 1897/4885ALDH1A1 837/4885CYP3A4 1562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.